Skip to main content

Table 1 The names, IDs, targets, and pathways of the 7 drugs

From: Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model

Drug name

Drug ID

Drug target

Target Pathway

Screening Set

BMS-754807

184

IGF1R, IR

RTK signaling

GDSC1

NU7441

1038

DNAPK

Genome integrity

GDSC1

RO-3306

1052

CDK1

Cell cycle

GDSC1

JQ1

1218

BRD2, BRD3, BRD4, BRDT

Chromatin other

GDSC1

AZD8186

1444

PI3Kbeta, PI3Kdelta

PI3K/MTOR signaling

GDSC1

AZD8055

1059

MTORC1, MTORC2

PI3K/MTOR signaling

GDSC1

SB216763

1025

GSK3A, GSK3B

WNT signaling

GDSC1